These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32503495)

  • 1. Community-based door to door census of suspected people living with epilepsy: empowering community drug distributors to improve the provision of care to rural communities in Cameroon.
    Kamgno J; Tchatchueng-Mbougua JB; Nana-Djeunga HC; Esso L; Zouré HG; Mackenzie CD; Boussinesq M
    BMC Public Health; 2020 Jun; 20(1):871. PubMed ID: 32503495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon.
    Boullé C; Njamnshi AK; Dema F; Mengnjo MK; Siewe Fodjo JN; Bissek AZ; Suykerbuyk P; Lenou-Nanga CG; Nana-Djeunga HC; Kamgno J; Chesnais CB; Boussinesq M; Colebunders R
    Parasit Vectors; 2019 Mar; 12(1):114. PubMed ID: 30890155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmatic factors associated with the limited impact of Community-Directed Treatment with Ivermectin to control Onchocerciasis in three drainage basins of South West Cameroon.
    Duamor CT; Datchoua-Poutcheu FR; Chounna Ndongmo WP; Yoah AT; Njukang E; Kah E; Maingeh MS; Kengne-Ouaffo JA; Tayong DB; Enyong PA; Wanji S
    PLoS Negl Trop Dis; 2017 Nov; 11(11):e0005966. PubMed ID: 29155826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentations of onchocerciasis-associated epilepsy (OAE) in Cameroon.
    Siewe JFN; Ngarka L; Tatah G; Mengnjo MK; Nfor LN; Chokote ES; Boullé C; Nkouonlack C; Dema F; Nkoro GA; Njamnshi WY; Tabah EN; Zoung-Kanyi Bissek AC; Colebunders R; Njamnshi AK
    Epilepsy Behav; 2019 Jan; 90():70-78. PubMed ID: 30513438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution and performance of female Community-Directed Distributors in the treatment of onchocerciasis with Ivermectin in Sub-Saharan Africa: a systematic review.
    Vouking MZ; Tamo VC; Tadenfok CN
    Pan Afr Med J; 2015; 20():188. PubMed ID: 26430485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-centre study of community-directed ivermectin distributors' (CDDs') involvement in other healthcare and development programme activities in Cameroon, Togo, Sudan, Nigeria and Uganda.
    Sama MT; Homeida M; Ngang P; Liese BH; Amazigo U; Seketeli A
    Trop Doct; 2003 Oct; 33(4):237-41. PubMed ID: 14620432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers to the National Onchocerciasis Control Programme at operational level in Cameroon: a qualitative assessment of stakeholders' views.
    Dissak-Delon FN; Kamga GR; Humblet PC; Robert A; Souopgui J; Kamgno J; Ghogomu SM; Godin I
    Parasit Vectors; 2019 May; 12(1):246. PubMed ID: 31109348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin.
    Mmbando BP; Suykerbuyk P; Mnacho M; Kakorozya A; Matuja W; Hendy A; Greter H; Makunde WH; Colebunders R
    Infect Dis Poverty; 2018 Jun; 7(1):64. PubMed ID: 29921319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of epilepsy in a village in the Littoral Province of Cameroon.
    Prischich F; De Rinaldis M; Bruno F; Egeo G; Santori C; Zappaterreno A; Fattouch J; Di Bonaventura C; Bada J; Russo G; Pizzuti A; Cardona F; Sa'a ; Vullo V; Giallonardo AT; D'Erasmo E; Pelliccia A; Vanacore N
    Epilepsy Res; 2008 Dec; 82(2-3):200-10. PubMed ID: 18976884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community-directed treatment of onchocerciasis with ivermectin in Takum, Nigeria.
    Akogun OB; Audu Z; Weiss MG; Adelakun AO; Akoh JI; Akogun MK; Remme H; Kale OO
    Trop Med Int Health; 2001 Mar; 6(3):232-43. PubMed ID: 11299041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community-directed health (CDH) workers enhance the performance and sustainability of CDH programmes: experience from ivermectin distribution in Uganda.
    Katabarwa MN; Richards FO
    Ann Trop Med Parasitol; 2001 Apr; 95(3):275-86. PubMed ID: 11339887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to ivermectin is more associated with perceptions of community directed treatment with ivermectin organization than with onchocerciasis beliefs.
    Dissak-Delon FN; Kamga GR; Humblet PC; Robert A; Souopgui J; Kamgno J; Essi MJ; Ghogomu SM; Godin I
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005849. PubMed ID: 28806785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin.
    Siewe Fodjo JN; Tatah G; Tabah EN; Ngarka L; Nfor LN; Chokote SE; Mengnjo MK; Dema F; Sitouok AT; Nkoro G; Ntone FE; Bissek AZ; Chesnais CB; Boussinesq M; Colebunders R; Njamnshi AK
    Infect Dis Poverty; 2018 Dec; 7(1):114. PubMed ID: 30501640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additional health and development activities for community-directed distributors of ivermectin: threat or opportunity for onchocerciasis control?
    Okeibunor JC; Ogungbemi MK; Sama M; Gbeleou SC; Oyene U; Remme JH
    Trop Med Int Health; 2004 Aug; 9(8):887-96. PubMed ID: 15303994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence and subjective handicap of epilepsy in Ilie--a rural riverine community in South West Nigeria: a door-to-door survey.
    Mustapha AF; Preux PM; Sanya EO; Akinleye CA
    Epilepsy Behav; 2014 Aug; 37():258-64. PubMed ID: 25112557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-directed distributors-The "foot soldiers" in the fight to control and eliminate neglected tropical diseases.
    Amazigo UV; Leak SGA; Zoure HGM; Okoronkwo C; Diop Ly M; Isiyaku S; Crump A; Okeibunor JC; Boatin B
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009088. PubMed ID: 33661903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are census data accurate for estimating coverage of a lymphatic filariasis MDA campaign? Results of a survey in Sierra Leone.
    Kamara W; Zoerhoff KL; Toubali EH; Hodges MH; Bisanzio D; Chowdhury D; Sonnie M; Magbity E; Samai M; Conteh A; Macarthy F; Baker M; Koroma JB
    PLoS One; 2019; 14(12):e0224422. PubMed ID: 31856176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epilepsy prevalence, potential causes and social beliefs in Ebonyi State and Benue State, Nigeria.
    Osakwe C; Otte WM; Alo C
    Epilepsy Res; 2014 Feb; 108(2):316-26. PubMed ID: 24300028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographic impact of epilepsy in Africa: results of a 10-year cohort study in a rural area of Cameroon.
    Kamgno J; Pion SD; Boussinesq M
    Epilepsia; 2003 Jul; 44(7):956-63. PubMed ID: 12823580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting the attrition of community-directed distributors of ivermectin, in an onchocerciasis-control programme in the Imo and Abia states of south-eastern Nigeria.
    Emukah EC; Enyinnaya U; Olaniran NS; Akpan EA; Hopkins DR; Miri ES; Amazigo U; Okoronkwo C; Stanley A; Rakers L; Richards FO; Katabarwa MN
    Ann Trop Med Parasitol; 2008 Jan; 102(1):45-51. PubMed ID: 18186977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.